Skip to content

A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02134795
Enrollment
6
Registered
2014-05-09
Start date
2014-05-31
Completion date
2014-09-30
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease

Brief summary

This is a single-center, open label study evaluating the acute effect of caloric vestibular stimulation on UPDRS motor scores in Parkinson's Disease patients.

Interventions

The noninvasive device is worn like a music headset and the patient lies back on a wedge pillow while the device is active. Each session lasts under 20 minutes.

Sponsors

Scion NeuroStim
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient should have a UPDRS motor score of 14 (off medication) or higher (mild to moderate) * Patient should have a Hoehn & Yahr staging of 1 to 3 (mild to moderate) * Patient must be an adult (18 years of age or older)

Exclusion criteria

* Women who are pregnant or nursing * have a history of significant cardiovascular disease (no pacemakers) * have a history of unstable mood disorder or unstable anxiety disorder or psychosis * use a hearing aid * have a cochlear implant * have been diagnosed with neurological disease other than Parkinson's disease. No atypical parkinsonism. * have a diagnosed vestibular dysfunction * abuse alcohol or other drugs * have had eye surgery within the previous three months or ear surgery within the previous six months * have active ear infections or a perforated tympanic membrane * have participated in another clinical trial within the last 30 days or are currently enrolled in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Motor UPDRS Score (Unified Parkinson's Disease Rating Scale)Changes in motor score at 25, 50, 75, 100, 130, 160 and 220 minutes relative to baselineA motor score prior to use of the device will be established (time zero), the motor test will be repeated after the first use of the device (times 25, 50, and 75 minutes), and then after a second use of the device (times 100, 130, 160 and 220). Any changes in motor scores at the various time points will be noted. A videotape of the motor UPDRS examination will be obtained at baseline and during the final test.

Countries

United States

Participant flow

Participants by arm

ArmCount
Caloric Vestibular Stimulation (CVS)
ThermoNeuroModulation (TNM) device with a standardized active CVS waveform will be used for all patients. The device will be used twice for \ 19 minutes each time. There will be a gap of roughly 1 hour between the two device applications. The device is worn like a music headset and the patient lies on a wedge pillow while the device is active. Each session lasts under 20 minutes.
6
Total6

Baseline characteristics

CharacteristicCaloric Vestibular Stimulation (CVS)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
Region of Enrollment
United States
6 Participants
Sex/Gender, Customized
Unknown
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 6
other
Total, other adverse events
0 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Motor UPDRS Score (Unified Parkinson's Disease Rating Scale)

A motor score prior to use of the device will be established (time zero), the motor test will be repeated after the first use of the device (times 25, 50, and 75 minutes), and then after a second use of the device (times 100, 130, 160 and 220). Any changes in motor scores at the various time points will be noted. A videotape of the motor UPDRS examination will be obtained at baseline and during the final test.

Time frame: Changes in motor score at 25, 50, 75, 100, 130, 160 and 220 minutes relative to baseline

Population: The study was halted early before any of the participants could complete this endpoint. Therefore, there is no outcome data to analyze.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026